TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Change in volumetric Bone Mineral Density (BMD)/bone microarchitecture
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in areal Bone Mineral Density (BMD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Columbia Suicide Severity Rating Scale Screener (C-SSRS) Uptake
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Comprehensive Suicide Risk Evaluation (CSRE) Uptake
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Mentalizing Task Related (MTR) neural activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Percentage of patients with Textbook outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical atrial fibrillation (AF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Major adverse cerebro-cardiovascular events (MACCE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: effectiveness of treatment with TENS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Comparison of MRI findings with pathologic results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Thickness of rectus femoralis and vastus intermedius
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Shape of the femoral nerve
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in skin carotenoid status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Diagnosis of Chronic thromboembolic pulmonary hypertension (CTEPH)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Imaging response to treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Slope of Curve for SNR Loss Scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Alleviation of symptoms or complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Agitation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Delirium Severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With Adverse Events - Bradycardia
Endpoint domain: Adverse events/effects
Primary endpoint: Superiority of 56-day BID treatment with SM-020 gel 1.0% over 28-day BID treatment with SM-020 gel 1.0%
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Superiority of 28-day BID treatment with SM-020 gel 1.0% over 28-day QD treatment with SM-020 gel 1.0%
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Superiority of 28-day BID treatment with SM-020 gel 1.0% over 28-day BID treatment with SM-020 gel 0.1%
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visual Analogue Scale Mean Scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Prevalence of hypovitaminose C
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Concentration of fecal bile acids
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: lesion healing rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post Obturation pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tenderness to percussion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Knee Injury and Osteoarthritis Outcome - Joint Replacement (KOOS, JR)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Outpatient Physical Therapy Visit Utilization
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Agreement of ICG/FA and LSCI findings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visual Function Classification System (VFCS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative Visual Analogue Scale (VAS) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Arthritis scored by DAS28 score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ESR in mm/hr
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CRP mg/dL
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement of KOOS score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Improvement of VAS Pain Score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: EDE-Q Weight and Shape Concern
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Sociocultural Attitudes Towards Appearance Questionnaire-4
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Weight Bias Internalization Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Reduction in Knee Pain
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: App usage
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Change from baseline Macular Pigment Density
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Seroclearance of HBsAg
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in Social Adjustment Scale II
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Change in Heinrich Quality of Life Scale
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in Social Skills Performance Assessment
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Generalized Anxiety Disorder-7 Anxiety Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in the Number of Participants Completing HIV Self-Testing
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Percentage of disease recurrence
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants With Suicidal Ideation
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants With a Gap in HIV Care Engagement
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: HIV Medication Adherence, as Measured by Number of Participants Who Report Adherence Challenges
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Aphasic quotient
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Copenhagen Hip and Groin Outcome Score (HAGOS)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: International Hip Outcome Tool (iHOT-12)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: European Quality of life questionnaire (EQ-5D-5L)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Eligibility Rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Drop out
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Isometric Knee Extension Muscle Strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Nasopharyngeal SARS-CoV-2 Viral Load
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Boston Bowel Preparation Scale inter and intra-observer variability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reoperation rates for the same diagnosis
Endpoint domain: Adverse events/effects
Primary endpoint: Toronto Side Effects Scale (TSES)
Endpoint domain: Adverse events/effects
Primary endpoint: Change from posttraumatic symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from psychopathological symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Dissociative symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Regression of size of cervical lymph nodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Lymphatic system outcomes
Primary endpoint: Change from Baseline Patient Health Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Intra-ocular pressure variation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Take rate of cultured epidermal autograft
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: The incidence of serious adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Change in the latency of first vection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in the vection frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in the vection duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in the vection intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Cohen-Mansfield Agitation Inventory (CMAI)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Vitamin D (25OHD) blood level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Fetal Growth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 18F-FAPI-RGD and 18F-FDG uptake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change from baseline QoR-15
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: OSA status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PA-eradication rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of clinically significant changes in clinical laboratory results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: knowledge test average score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: System Usability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Technology Acceptance
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Half-life of sotrovimab (VIR-7831) post-transplant
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in diagnosis and/or patient management
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total number of effective days with ANC > 0.5×10^9/L
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change from baseline in Left ventricular ejection fraction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in Attention Network Test (ANT) performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in task-based functional connectivity during ANT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in mental health scores (GAD-7)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in mental health scores (PHQ-8)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in mental health scores (Edinburgh Postnatal Depression Score)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: The Morton Mobility Index (DEMMI)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Esslinger Transfer Scale
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Behavioral Intention to smoke cigarette
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Behavioral Intention to drink alcohol
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Behavioral Intention to chew khat
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Virological response variability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Undetectability evidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline depressive symptoms at first month
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline caregiver care burden at first month
Endpoint domain: Life impact
Endpoint subdomain: Societal/carer burden
Primary endpoint: Change from baseline caregivers' quality of life at first month
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: unplanned extubation
Endpoint domain: Adverse events/effects
Primary endpoint: Mean change from baseline in skin hydration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Changes from baseline in objective dermatological evaluation of skin status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Interruption of transmission of T.b. gambiense
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Cognitive State Assessment
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Assessment of Exercise Capacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Assessment of Perceived Fatigue Severity After Exercise Test
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Incidence of adverse events/serious adverse events/special interest adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Number of patients with positive FVII inhibitor, anti-drug antibody
Endpoint domain: Adverse events/effects
Primary endpoint: Score of Child Depression Rating Scale-Revised
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Score of Beck Scale for Suicide Ideation
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in working memory test scores after intervention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dosages of hypnotics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reduction in treatment failure
Endpoint domain: Mortality/survival
Primary endpoint: Postoperative Emergence Delirium
Endpoint domain: Adverse events/effects
Primary endpoint: Risk of developing nosocomial infections during ICU admission
Endpoint domain: Adverse events/effects
Primary endpoint: Severity of illness measured by APACHE score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severity of illness measured by SOFA score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severity of illness measured by MODS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Child Psychiatric Symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: brain changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Incidence of defects in impression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Remission rate with IL5/IL5R antagonists
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of MACCE
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Pain measurement using Visual Analogue Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Covid-19 Neutralizing Antibodies Measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Wood-Downes-Ferres clinical score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline Boston Carpal Tunnel Questionnaire (BCTQ)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Intraoperative electromyographic signals
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Voice analysis data(SPL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Voice analysis data(F0)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Voice analysis data(Jitter)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Voice analysis data(Shimmer)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Basic metabolic profile
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Adipokines
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Serum Interleukin-15 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Serum Interleukin-22 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change of Fatigue Severity Score
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: GFR changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Identification of mutation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: FPR1 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Concordance between digital biomarker and celiac disease-related symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain level assessed by NRS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Chemosensitivity of carotid bodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: morbidity rates
Endpoint domain: Mortality/survival
Primary endpoint: parietal peritoneal fibrosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Resting state electroencephalogram (EEG)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Fugl-Meyer Assessment - Upper extremity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient Experience Survey -- Overall Care (all participants)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Readmission intensity
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Proportional change in gait function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Wellbeing
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Color change after tooth whitening
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean naloxone plasma concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of repeated tube placement
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: 5-Year Disease-Free Survival
Endpoint domain: Mortality/survival
Primary endpoint: activity of the anti-Xa factor
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in nasal polyps score at week 24
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in nasal congestion score at week 24
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Major cardiovascular event rate after medication
Endpoint domain: Adverse events/effects
Primary endpoint: Number and result of urine screening tests
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of visits scheduled and kept with PCP
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Objective Response Rate (Cohort A)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the plasma concentration-time curve (AUC) from time zero to infinity (AUC0-∞)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC from time zero to the last measurable concentration (AUC0-last)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall response rate after 2 cycles of chemotherapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall response rate after 4 cycles of chemotherapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Grade 3-4 Adverse events incidence
Endpoint domain: Adverse events/effects
Primary endpoint: Change in homocysteine levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Time to urinary continence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Surfactant protein (SP)-D in serum
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Club cell protein 16 (CC16)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in Melasma Area and Severity Index score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Local Skin Reaction (LSR) total score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes